# Total Dose Iron Dextran Infusion in Cancer Patients: Is it SaFe<sup>2+</sup>?

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/total-dose-iron-dextran-infusion-in-cancer-patients-is-it-safe-sup-2-sup/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jeffrey A. Gilreath,David D. Stenehjem,George M. Rodgers |
| Citations | 17 |
| DOI | 10.6004/jnccn.2012.0066 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://jnccn.org/downloadpdf/journals/jnccn/10/5/article-p669.pdf |
| OpenAlex ID | https://openalex.org/W1851319163 |
| PMID | 22570295 |
| Type | article |
| Year | 2012 |

## Paper authors

- [Jeffrey A. Gilreath](https://scholariq.org/researchers/jeffrey-a-gilreath/)
- [David D. Stenehjem](https://scholariq.org/researchers/david-d-stenehjem/)
- [George M. Rodgers](https://scholariq.org/researchers/george-m-rodgers/)

## Paper journal

- [Journal of the National Comprehensive Cancer Network](https://scholariq.org/journals/journal-of-the-national-comprehensive-cancer-network/)

## Paper primary topic

- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)

## Paper topics

- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)
- [Iron Metabolism and Disorders](https://scholariq.org/topics/iron-metabolism-and-disorders/)
- [Hemoglobinopathies and Related Disorders](https://scholariq.org/topics/hemoglobinopathies-and-related-disorders/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.